Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-20-003886
Filing Date
2020-11-13
Accepted
2020-11-13 08:11:39
Documents
43
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT odyssey_10qa1-013120.htm 10-Q/A 412601
2 CERTIFICATION odyssey_ex3101.htm EX-31.1 7634
3 CERTIFICATION odyssey_ex3102.htm EX-31.2 7402
4 CERTIFICATION odyssey_ex32.htm EX-32 3312
  Complete submission text file 0001683168-20-003886.txt   2037114

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE odyy-20200131.xml EX-101.INS 452675
6 XBRL SCHEMA FILE odyy-20200131.xsd EX-101.SCH 18925
7 XBRL CALCULATION FILE odyy-20200131_cal.xml EX-101.CAL 27337
8 XBRL DEFINITION FILE odyy-20200131_def.xml EX-101.DEF 45812
9 XBRL LABEL FILE odyy-20200131_lab.xml EX-101.LAB 119160
10 XBRL PRESENTATION FILE odyy-20200131_pre.xml EX-101.PRE 99356
Mailing Address 2372 MORSE AVE. IRVINE CA 92614
Business Address 2372 MORSE AVE. IRVINE CA 92614 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 000-56196 | Film No.: 201309225
SIC: 3841 Surgical & Medical Instruments & Apparatus